2 unchanged sentences
Our Class A common shares are listed on The Nasdaq Global Select Market under the symbol “KNSA.”
−Removed: As of January 31, 2021, there were 16 holders of record of our Class A common shares, five holders of record of our Class B common shares, four holders of record of our Class A1 common shares and two holders of record of our Class B1 common shares.
+Added: As of January 31, 2022, there were nine holders of record of our Class A common shares, four holders of record of our Class B common shares, three holders of record of our Class A1 common shares and two holders of record of our Class B1 common shares.
The actual number of shareholders is greater than this number of record holders, and includes shareholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees.
7 unchanged sentences
Recent Sales of Unregistered Securities
−Removed: On May 18, 2020, we issued and sold an aggregate of 1,600,000 Class A1 common shares to existing investors at price of $18.25 per share, resulting in aggregate gross proceeds to us of approximately $29.2 million.
−Removed: These securities were issued under Section 4(a)(2) of the Securities Act in a transaction not involving a public offering.
−Removed: On June 6, 2020, we issued an aggregate of 59,469 Class A common shares to the former shareholders of Primatope, having an aggregate value of approximately less than $0.1 million, in connection with the release and issuance of the shares held back at the closing of the acquisition of Primatope, in accordance with the Primatope Agreement.
−Removed: These securities were issued under Section 4(a)(2) and Rule 506 of the Securities Act in a transaction not involving a public offering.
−Removed: On July 24, 2020, we issued and sold an aggregate of 1,428,572 Class A1 common shares to existing investors at a price of $21.00 per share, resulting in aggregate gross proceeds to us of approximately $30.0 million.
−Removed: These securities were issued under Section 4(a)(2) of the Securities Act in a transaction not involving a public offering.
−Removed: On September 4, 2020, we issued an aggregate of 16,634 Class A common shares to the former shareholders of Primatope, having an aggregate value of approximately $0.3 million, as payment, in part, for the achievement of a milestone in accordance with the Primatope Agreement.
−Removed: These securities were issued under Section 4(a)(2) and Rule 506 of the Securities Act in a transaction not involving a public offering.
+Added: Not applicable.
Use of Proceeds from Registered Securities
−Removed: On May 29, 2018, we issued and sold 8,477,777 Class A common shares to the underwriters in our initial public offering, or IPO, and on June 22, 2018, we issued and sold an additional 1,006,425 Class A common shares pursuant to the exercise by the underwriters of their over-allotment option to purchase additional shares.
−Removed: Our Class A common shares were sold at a price to the public of $18.00 per share.
−Removed: We received aggregate gross proceeds from the IPO inclusive of the underwriters’ over-allotment option of approximately $170.7 million and aggregate net proceeds of approximately $155.5 million after deducting underwriting discounts and commissions of approximately $12.0 million and other offering expenses.
−Removed: The offer and sale of all of the shares in our IPO inclusive of the underwriters’ over-allotment option were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No.
−Removed: 333-224488), which was declared effective by the Securities and Exchange Commission, or SEC, on May 23, 2018, and a registration statement on Form S-1 to register additional shares (File No.
−Removed: 333-225159), which was automatically effective upon filing with the SEC on May 23, 2018.
−Removed: There has been no material change in our planned use of the net proceeds from the IPO as described in our final prospectus filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC on May 24, 2018.
−Removed: As of December 31, 2020, we had used all of the net proceeds from our initial public offering.
−Removed: SELECTED CONSOLIDATED FINANCIAL DATA.
−Removed: You should read the following selected consolidated financial data together with our consolidated financial statements and the related notes included elsewhere in this Annual Report and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of this Annual Report.
−Removed: We have derived the consolidated statement of operations data for the years ended December 31, 2020, 2019 and 2018 and the consolidated balance sheet data as of December 31, 2020 and 2019 from our audited consolidated financial statements included elsewhere in this Annual Report.
−Removed: Our historical results are not necessarily indicative of results that may be expected in any future period.
−Removed: (in thousands, except share and per share data)
−Removed: Consolidated Statement of Operations Data:
−Removed: Operating expenses:
−Removed: Research and development
−Removed: Selling, general and administrative
−Removed: Total operating expenses
−Removed: Loss from operations
−Removed: Interest income
−Removed: Loss before (provision) benefit for income taxes
−Removed: (Provision) benefit for income taxes
−Removed: Net loss per share attributable to common shareholders—basic and diluted (1)
−Removed: Weighted average common shares outstanding—basic and diluted (1)
−Removed: See Note 12 to our consolidated financial statements included elsewhere in this Annual Report for further details on the calculation of basic and diluted net loss per share attributable to common shareholders.
−Removed: (in thousands)
−Removed: Consolidated Balance Sheet Data:
−Removed: Cash, cash equivalents and short-term investments
−Removed: Working capital (1)
−Removed: Accumulated deficit
−Removed: Total shareholders’ equity
−Removed: We define working capital as current assets less current liabilities.
+Added: Not applicable.
+Added: Issuer Purchases of Equity Securities
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.